John Turnidge

7PUBLICATIONS
16CO-AUTHORS
Health and ecological risk assessmentInfectious agentsMedical mycologyEnvironmental biogeochemistryMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 22, 2026
Novel EUCAST-approved quality control range for Escherichia coli ATCC® 25922 and cefoperazone 30 µg discs.

|Nov 11, 2024
Reflections on community antimicrobial use in Australia.

John Turnidge, Carolyn Hullick, Kim Stewart

|Dec 01, 2023
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utility.

Gunnar Kahlmeter, John Turnidge

|Oct 03, 2023
The scope of antimicrobial resistance in residential aged care facilities determined through analysis of <i>Escherichia coli</i> and the total wastewater resistome.

Sylvia A Sapula, Anteneh Amsalu, Jon J Whittall

|Aug 16, 2022
Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact.

Maryza Graham, Debra Graves, Louise Cooley

|Aug 09, 2021
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability.

A Espinel-Ingroff, M Sasso, J Turnidge

Pageof 2

Frequent Collaborators

1 joint publications

A Espinel-Ingroff

1 joint publications

M Sasso

1 joint publications

M Arendrup

1 joint publications

E Dannaoui